Source: http://www.legis.state.wv.us/Bill_Status/bills_text.cfm?billdoc=SB336%20SUB1.htm&yr=2014&sesstype=RS&i=336
Timestamp: 2017-08-23 04:34:39
Document Index: 262117269

Matched Legal Cases: ['§16', '§16', '§30', '§16', '§16', '§30', '§16', '§16', '§30']

SB 336 Text
SB336 SUB1 Senate Bill 336 History
OTHER VERSIONS - Introduced Version | Committee Substitute (2) | | Email
Senate Bill No. 336
(By Senators Stollings, Laird, Boley, Cole, M. Hall,
Kirkendoll, Miller, Palumbo, Plymale, Prezioso,
Tucker, Walters, Yost, Jenkins and Cookman)
[Originating in the Committee on Health and Human Resources;
reported January 31, 2014.]
A BILL to amend the Code of West Virginia, 1931, as amended, by adding thereto two new sections, designated §16-4C-24 and §16-4C-25; and to amend and reenact §30-1-7a of said code, all relating generally to administration of an opioid antagonist; allowing State Police, police, sheriffs and fire and emergency service personnel to possess Naloxone or other approved opioid antagonist to administer in opioid drug overdoses; defining terms; providing for training; establishing training requirements for first responders who may administer opioid antagonists; establishing criteria under which a first responder may administer an opioid antagonist; granting immunity to health care providers who prescribe, dispense or distribute Naloxone or other approved opioid antagonist related to a training program; granting immunity to initial responders who administer or fail to administer an opioid antagonist; providing for data gathering and reporting; allowing a prescription for an opioid antagonist in certain circumstances; establishing responsibility of licensed prescribers; providing for patient family and caregiver education; requiring continuing education of licensed prescribers for administration of an opioid antagonist; and authorizing emergency and legislative rulemaking.
That the Code of West Virginia, 1931, as amended, be amended by adding thereto two new sections, designated §16-4C-24 and §16-4C-25, and that §30-1-7a of said code be amended and reenacted, all to read as follows:
ARTICLE 4C. EMERGENCY MEDICAL SERVICES ACT.
§16-4C-24. Administration of an opioid antidote in an emergency situation.
(a) For purposes of this section:
(1) “Initial responder” means an emergency medical service personnel covered under this article and a member of the State Police, a sheriff, a deputy sheriff, a municipal police officer, a volunteer or paid firefighter and any other similar person who responds to emergencies.
(2) “Licensed health care provider” means a person, partnership, corporation, professional limited liability company, health care facility or institution licensed by or certified in this state to provide health care or professional health care services, including, but not limited to, a physician, osteopathic physician, hospital or emergency medical service agency.
(3) "Opioid antagonist" means naloxone hydrochloride or other substance that is approved by the federal Food and Drug Administration for the treatment of a drug overdose by intranasal administration.
(4) "Opioid overdose prevention and treatment training program" or "program" means any program operated or approved by the Office of Emergency Medical Services as set forth in rules promulgated pursuant to subsection (f) of this section.
(b) A licensed health care provider who is permitted by law to prescribe an opioid antagonist may, if acting with reasonable care, prescribe and subsequently dispense or distribute an opioid antagonist in conjunction with an opioid overdose prevention and treatment training program, without being subject to civil liability or criminal prosecution, unless the act was the result of the licensed health care provider’s gross negligence or willful misconduct. This immunity applies only to the licensed health care provider even when the opioid antagonist is administered by and to someone other than the person to whom it is prescribed.
(c) An initial responder who is not otherwise to administer an opioid antagonist may administer an opioid antagonist in an emergency situation if:
(1) The initial responder has successfully completed the training required by subdivision (4), subsection (a) of this section; and
(2) The administration of the opioid antagonist is done after consultation with medical command personnel: Provided, That an initial responder who otherwise meets the qualifications of this subsection may administer an opioid antagonist without consulting with medical command if he or she is unable to so consult due to an inability to contact medical command because of circumstances outside the control of the initial responder or if there is insufficient time for the consultation based upon the emergency conditions presented.
(d) An initial responder who meets the requirements of subsection (c) of this section, acting in good faith, is not, as a result of his or her actions or omissions, liable for any violation of any professional licensing statute, subject to criminal prosecution arising from or relating to the unauthorized practice of medicine or the possession of an opioid antagonist or subject to any civil liability with respect to the administration of or failure to administer the opioid antagonist unless the act or failure to act was the result of the initial responder’s gross negligence or willful misconduct.
(e) Data regarding each opioid overdose prevention and treatment program that the Office of Emergency Medical Services operates or recognizes as an approved program shall be collected and reported by January 1, 2017, to the Legislative Oversight Commission on Health and Human Resources Accountability. The data collected and reported shall include:
(1) The number of training programs operating in an Office of Emergency Medical Services designated training center;
(2) The number of individuals who have received training to administer an opioid antagonist;
(3) The number of individuals who received the opioid antagonist who were revived;
(4) Number of individuals who received the opioid antagonist who were not revived; and
(5) Number of adverse events associated with an opioid overdose prevention and treatment program, including a description of the adverse events.
(f) To implement the provisions of this section, including establishing the standards for certification and approval of opioid overdose prevention and treatment training programs and protocols regarding a refusal to transport, the Office of Emergency Medical Services may promulgate emergency and legislative rules pursuant to the provisions of section fifteen, article three, chapter twenty-nine-a of this code.
§16-4C-25. Offer of Emergency Aid Medication to Patients Prescribed Opiates.
(a) All prescribers in the course of their professional practice may offer to patients to whom they also prescribe opiates for chronic pain or patients engaged in methadone or suboxone treatment programs, a prescription for an opioid antagonist such as Naloxone.
(b) All prescribers who may offer an opioid antagonist to their patients under this section shall make information and education available to patients, their family members, or caregivers on the beneficial and proper use of the opioid antagonist.
(c) When a prescription is written to a patient for an opioid antagonist, or if the patient enters a methadone or subonxone addiction treatment program, information and education is required to given to the patient and his or her family or caregiver as a condition of receiving the prescription or entering an addiction treatment program.
§30-1-7a. Continuing education.
(a) Each board referred to in this chapter shall establish continuing education requirements as a prerequisite to license renewal. Each board shall develop continuing education criteria appropriate to its discipline, which shall include, but not be limited to, course content, course approval, hours required and reporting periods.
(b) Notwithstanding any other provision of this code or the provision of any rule to the contrary, each person issued a license to practice medicine and surgery or a license to practice podiatry or licensed as a physician assistant by the West Virginia Board of Medicine, each person issued a license to practice dentistry by the West Virginia Board of Dental Examiners, each person issued a license to practice optometry by the West Virginia Board of Optometry, each person licensed as a pharmacist by the West Virginia Board of Pharmacy, each person licensed to practice registered professional nursing or licensed as an advanced nurse practitioner by the West Virginia Board of Examiners for Registered Professional Nurses, each person licensed as a licensed practical nurse by the West Virginia State Board of Examiners for Licensed Practical Nurses and each person licensed to practice medicine and surgery as an osteopathic physician and surgeon or licensed or certified as an osteopathic physician assistant by the West Virginia Board of Osteopathy shall complete drug diversion training, and best practice prescribing of controlled substances training and training on prescribing and administration of an opioid antagonist, as the trainings are established by his or her respective licensing board, if that person prescribes, administers, or dispenses a controlled substance, as that term is defined in section one hundred one, article one, chapter sixty-a of this code.
(1) Notwithstanding any other provision of this code or the provision of any rule to the contrary, the West Virginia Board of Medicine, the West Virginia Board of Dental Examiners, the West Virginia Board of Optometry, the West Virginia Board of Pharmacy, the West Virginia Board of Examiners for Registered Professional Nurses, the West Virginia State Board of Examiners for Licensed Practical Nurses and the West Virginia Board of Osteopathy shall establish continuing education requirements and criteria appropriate to their respective discipline on the subject of drug diversion training, and best practice prescribing of controlled substances training and prescribing and administration of an opioid antagonist training for each person issued a license or certificate by their respective board who prescribes, administers or dispenses a controlled substance, as that term is defined in section one hundred one, article one, chapter sixty-a of this code, and shall develop a certification form pursuant to subdivision (b)(2) of this section.
(2) Each person who receives his or her initial license or certificate from any of the boards set forth in subsection (b) shall complete the continuing education requirements set forth in subsection (b) within one year of receiving his or her initial license from that board and each person licensed or certified by any of the boards set forth in subsection (b) who has held his or her license or certificate for longer than one year shall complete the continuing education requirements set forth in subsection (b) as a prerequisite to each license renewal: Provided, That a person subject to subsection (b) may waive the continuing education requirements for license renewal set forth in subsection (b) if he or she completes and submits to his or her licensing board a certification form developed by his or her licensing board attesting that he or she has not prescribed, administered, or dispensed a controlled substance, as that term is defined in section one hundred one, article one, chapter sixty-a of this code, during the entire applicable reporting period.